The new generation drug candidate molecules: Spectral, electrochemical, DNA-binding and anticancer activity properties

15 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

1. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesCitations 12 · OpenAlex
2. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesCitations 12 · OpenAlex
3. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesCitations 12 · OpenAlex
4. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesCitations 12 · OpenAlex
5. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsCitations 3 · OpenAlex
6. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsCitations 3 · OpenAlex
7. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsCitations 3 · OpenAlex
8. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsCitations 3 · OpenAlex
9. 2024 New metal-based drugs: spectral, electrochemical, DNA-binding and anticancer activity propertiesCitations 1 · OpenAlex
10. 2024 New metal-based drugs: spectral, electrochemical, DNA-binding and anticancer activity propertiesCitations 1 · OpenAlex